355 related articles for article (PubMed ID: 23938135)
21. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.
Pech O; May A; Manner H; Behrens A; Pohl J; Weferling M; Hartmann U; Manner N; Huijsmans J; Gossner L; Rabenstein T; Vieth M; Stolte M; Ell C
Gastroenterology; 2014 Mar; 146(3):652-660.e1. PubMed ID: 24269290
[TBL] [Abstract][Full Text] [Related]
22. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
23. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
Gilbert S; Jobe BA
Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
[TBL] [Abstract][Full Text] [Related]
25. [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia].
Catrambone G; Leoncini G; Iurilli L; Queirolo A; Spinelli A; Taviani M; Mazzarino S
Minerva Chir; 1999 Oct; 54(10):657-67. PubMed ID: 10575887
[TBL] [Abstract][Full Text] [Related]
26. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus.
Kariyawasam VC; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; Fanning SB; Chung AM; Byth K
Gastrointest Endosc; 2012 May; 75(5):938-44. PubMed ID: 22381529
[TBL] [Abstract][Full Text] [Related]
27. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
[TBL] [Abstract][Full Text] [Related]
28. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Watson TJ
Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
[TBL] [Abstract][Full Text] [Related]
31. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Heitmiller RF; Redmond M; Hamilton SR
Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
[TBL] [Abstract][Full Text] [Related]
33. Oesophagectomy is a safe option for early adenocarcinoma arising from Barrett's oesophagus.
Lam YH; Bright T; Leong M; Thompson SK; Mayne G; Watson DI
ANZ J Surg; 2016 Nov; 86(11):905-909. PubMed ID: 25708344
[TBL] [Abstract][Full Text] [Related]
34. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus.
Nijhawan PK; Wang KK
Gastrointest Endosc; 2000 Sep; 52(3):328-32. PubMed ID: 10968845
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
38. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy.
Ferguson MK; Naunheim KS
J Thorac Cardiovasc Surg; 1997 Nov; 114(5):824-9. PubMed ID: 9375613
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
40. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ; Gable DR; Lentsch AB; Richardson JD
Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
